The Effects of Pioglitazone on Respiratory Function Test in Patients with Asthma and Type 2 Diabetes Mellitus- A before –after Study

نویسندگان
Azizi, Reyhaneh ID 1
Namiranian, Nasim ID 2
Hassani Kaboutarkhani, Miaad ID 3
Gholami, Somaye ID 4
Jam Ashkezari, Saeedeh ID 5
Davoudi, Zahra ID 6
Aghaei Meybodi, Fatemeh ID 7

1 . Assistant Professor of Endocrinology, Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 Assistant Professor of Community and Preventive Medicine, Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

3 Medical Student, Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

4 Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

5 Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

6 Skull Base Research Center, Loghman Hakim Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

7 Assistant Professor, Department of Internal Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

doi
10.18502/ijdo.v11i4.2876
چکیده

Objective: Pioglitazone is one of the oral medications of type 2 diabetes (T2DM). The purpose of this study was to evaluate the effect of pioglitazone on asthma and diabetes treatment outcomes among patients with concurrent asthma and T2DM. Materials and Methods: We conducted a quasi-experimental study on 11 patients with concurrent asthma and T2DM in Yazd Afshar Hospital and ...

کلیدواژه‌ها
Bronchial asthma, Thiazolidinedione, Diabetes mellitus-type